Table 1.
Characteristics of included studies.
Studies | Number of Patients | Country | Time frame | Currency | Follow up | Additional info. | Average total cost per mRS (SD) |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | 4 | 5 | 6 | |||||||
Asil et al.10 | 328 | Turkey | January 2007– December 2007 | USD | Discharge | 1000 (729) | 1838 (1895) | 2777 (5792) | |||||
Baeten et al.11 | 338 | Netherlands | January 1999– January 2000 | Euro | 6 months | Stroke service | 8400 | 11,080 | 29,644 | 27,371 | |||
6 months | Usual Care | 9856 | 14,868 | 37,682 | 46,089 | ||||||||
12 months | Usual Care | 1761 | 4196 | 17,824 | 22,515 | ||||||||
Christensen et al.12 | 820 | Worldwide | May 2005– February 2007 | USD | 3 months | 9466 (4614) | 15,547 (7873) | 18,742 (9978) | 27,387 (11,621) | 27,281 (8,919) | 27,330 (11,495) | 8136 (3719) | |
(95% CI) | 7130– 11,902 | 13,336– 17,757 | 15,987– 21,496 | 24,372– 30,402 | 25,198– 29,364 | 22,182– 32,479 | 7421–9032 | ||||||
Christensen et al.13 | 167 | Argentina | January 2004– August 2006 | USD | Discharge | ICH | 1475 | 6370 | |||||
Discharge | IS | 1622 | 3188 | ||||||||||
Christensen et al.14 | 316 | Brazil | January 2006– May 2007 | USD | Discharge | ICH | 6307 | 30,693 | |||||
Discharge | IS | 1800 | 6771 | ||||||||||
Dawson et al.15 | 1717 | Worldwide | March 1998– May 1999 | GBP | 3 months | 2493 to 3412 | 3369 to 4479 | 5784 to 7008 | 7300 to 8515 | 10,095 to 11,141 | 11,772 to 13,560 | ||
Dodel et al.16 | 340 | Germany | January 2000– June 2000 | Euro | Discharge | 3160 (1300) | 4030 (2780) | ||||||
Epifanov et al.17 | 253 | Germany | January 1998– June 1998 | Euro | Discharge | 3,210 (2170) | 3350 (3050) | ||||||
Fattore et al.18 | 411 | Italy | August 2005– March 2007 | Euro | 0–3 months | 1225 | 3370 | 9185 | |||||
3–6 months | 343 | 1688 | 2335 | ||||||||||
6–12 months | 513 | 939 | 2182 | ||||||||||
12 month total | 1964 | 5239 | 13,381 | ||||||||||
Hayes et al.19 | 172 | USA | May 2001– September 2002 | USD | 3 months | 7044 | 6159 | 7885 | 11,723 | 22,156 | 18,670 | ||
3–12 months | 4321 | 5727 | 3994 | 6811 | 5154 | 9958 | |||||||
12 month total | 14,901 | 12,637 | 12,751 | 23,218 | 30,971 | 28,628 | |||||||
Luengo-Fernandez et al.20 | 153 | United Kingdom | April 2002– March 2007 | GBP | 3 months | 3945 (7558) | 17,406 (18,417) | 25,279 (16,396) | |||||
Annual costs | 2135 (3675) | 4165 (7668) | 6234 (14,898) | ||||||||||
Spieler et al.21 | 435 | France | Unavailable | Euro | 18 months | 10,255 | 17,457 | 31,728 | |||||
(95% CI) | 9679–10,831 | 14,46– 020,453 | 28,811–34,645 | ||||||||||
Tanny et al.9 | 378 | Australia | January 2003– December 2011 | USD | 3 months | 29,406 | 32,214 | 36,205 | 37,878 | 39,522 | 41,780 | 16,727 |
Note: Tan Tanny et al, calculated hospital costs from 378 patients based on actual expenditure sourced from the Clinical costing unit of Royal Melbourne Hospital and inputted these costs in the cost effectiveness model of thrombolysis treatment.